fgfr2/3 inhibitor cgt4859 vs derazantinib
| fgfr2/3 inhibitor cgt4859 | derazantinib | |
|---|---|---|
| Developers | 0 | 1 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | FGFR2/3 Inhibitor CGT4859 | ARQ 087 |
| fgfr2/3 inhibitor cgt4859 | derazantinib | |
|---|---|---|
| Developers | 0 | 1 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | FGFR2/3 Inhibitor CGT4859 | ARQ 087 |